Print Page     Close Window     

SEC Filings

10-K/A
BIOTIME INC filed this Form 10-K/A on 03/29/2017
Entire Document
 

(19)
Incorporated by reference to BioTime’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015

(20)
Incorporated by reference to Registration Statement on Form S-8, File Number 333-205661 filed with the Securities and Exchange Commission on July 15, 2015

(21)
Incorporated by reference to BioTime’s Quarterly Report on Form 10/Q for the quarter ended September 30, 2015

(22)
Incorporated by reference to BioTime’s Current Report on Form 8-K, filed November 16, 2015

(23)
Incorporated by reference to BioTime’s Current Report on Form 8-K, filed November 18, 2015

(24)
Incorporated by reference to BioTime’s Current Report on Form 8-K, filed November 24, 2015

(25)
Incorporated by reference to BioTime’s Current Report on Form 8-K, filed December 9, 2015

(26)
Incorporated by reference to BioTime’s Current Report on Form 8-K, filed February 18, 2016

(27)
Previously filed with BioTime’s Annual Report on Form 10-K for the year ended December 31, 2016, filed March 16, 2017

*
Filed herewith

(c)          Financial Statement Schedules of Subsidiaries Not Consolidated and Fifty Percent or Less Owned Persons

The following financial statements of Asterias Biotherapeutics, Inc. are incorporated by reference to the financial statements included in Asterias’ Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 28, 2017, and filed herewith as Exhibit 99.1.

Balance sheets as at December 31, 2016 and 2015
Statements of operations for the years ended December 31 2016, 2015, and 2014
Statements of comprehensive loss for the years ended December 31 2016, 2015, and 2014
Statement of stockholders’ equity for the years ended December 31 2016, 2015, and 2014
Statements of cash flows for the years ended December 31 2016, 2015, and 2014
Notes to Financial Statements
 

© Copyright BioTime, Inc.